Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Spero Therapeutics Inc (NASDAQ:SPRO)

Delayed Data
As of Jan 19
 0.00 / 0.00%
Today’s Change
Today|||52-Week Range

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Quarter 3



Revenue and IncomeNet Revenues597.0K------
Depreciation And Amortization94.0K------
Operating ExpensesGross Income----------
General Expenses10.5M------
Research And Development6.9M------
Total Operating Expenses10.6M------
Non-Operating ExpensesOperating Income-10.0M------
Extraordinary Charge-2.0K------
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-9.8M------
Minority Interest-8.0K------
Preferred Dividend-2.2M------
Net Income-9.8M------
Shares To Calculate EPSShares To Calculate EPS335.3K------
Shares To Calculate EPS Diluted335.3K------
Earnings Per ShareEPS-$36.02------
EPS Diluted-$36.02------